Cardioxane (Clinigen Healthcare Ltd)


Welcome to the PulseAid listing for the Cardioxane drug offered from Clinigen Healthcare Ltd. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Clinigen Healthcare Ltd
NON-PROPRIETARY NAME: dexrazoxane
SUBSTANCE NAME: DEXRAZOXANE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
START MARKETING DATE: 2017-07-28
END MARKETING DATE: 0000-00-00


Cardioxane HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCardioxane from Clinigen Healthcare Ltd
LABELER NAME: Clinigen Healthcare Ltd
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2017-07-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76310-002_5a881549-9d86-4ff7-b4ab-2cfb315f9af3
PRODUCT NDC: 76310-002
APPLICATION NUMBER:

Other DEXRAZOXANE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Dexrazoxane
Breckenridge Pharmaceutical, Inc.Dexrazoxane
Clinigen Healthcare LtdCardioxane
Cumberland Pharmaceuticals Inc.Totect
Gland Pharma LimitedDexrazoxane
Pharmacia and Upjohn Company LLCZinecard
ThyMoorgan GmbH Pharmazir & Co. K.GDexrazoxane
West-Ward Pharmaceuticals CorpDexrazoxane